Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancements to improve brain stimulation devices are expected to drive market growth.
4.1.2. Restraints:
4.1.2.1. The high cost of neurology devices are expected to hamper the market growth.
4.1.3. Opportunity
4.1.4. Impact Analysis

5. Industry Analysis
5.1. Porter’s Five Forces
5.2. Unmet Needs
5.3. Supply Chain
5.4. Pricing Analysis
5.5. Regulatory Analysis

6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product Segment
7.2. Cerebrospinal Fluid Management Devices*
7.2.1. Cerebral Shunts
7.2.2. Introduction
7.2.3. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.4. Cerebral External Drainage
7.3. Neurostimulation Devices
7.4. Implantable Devices
7.4.1. Vagus Nerve Stimulators
7.4.2. Spinal Cord Stimulators
7.4.3. Deep Brain Stimulators
7.4.4. Gastric Electric Stimulators
7.4.5. Others
7.5. External Devices
7.5.1. Transcranial Magnetic Stimulation (TMS)
7.5.2. Transcutaneous Electrical Nerve Stimulation (TENS)
7.5.3. Others
7.6. Interventional Neurology
7.6.1. Aneurysm Coiling and Embolization
7.6.1.1. Embolic Coils
7.6.1.2. Flow Diversion Devices
7.6.1.3. Liquid Embolic Reagents
7.6.2. Neurovascular Catheters
7.6.2.1. Micro Catheters
7.6.2.2. Micro Guidewires
7.6.3. Cerebral Balloon Angioplasty &Stents
7.6.3.1. Carotid Artery Stents
7.6.3.2. Filter Devices
7.6.3.3. Balloon Occlusion Devices
7.6.4. Neurothromobectomy
7.6.4.1. Clot Retrievers
7.6.4.2. Suction Aspiration Devices
7.6.4.3. Snare Devices
7.6.5. Neurosurgery Devices
7.6.5.1. Ultrasonic Aspirators
7.6.5.2. Stereotactic Systems
7.6.5.3. Neuroendoscopes
7.6.5.4. Aneurysm Clips
7.6.6. Others

8. By Disease Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
8.1.2. Market Attractiveness Index, By Disease Type Segment
8.2. Cerebral Aneurysms*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Fistulas and Arteriovenous Malformations
8.4. Ischemic Strokes
8.5. Carotid Artery Stenosis
8.6. Others

9. By End-user
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
9.1.2. Market Attractiveness Index, By End user Segment
9.2. Hospitals & Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Specialty Center
9.4. Others

10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles
12.1. Stryker Corporation*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Boston Scientific Corporation
12.3. Integra LifeSciences Holdings Corporation
12.4. Johnson and Johnson
12.5. Medtronic Inc.
12.6. Penumbra Inc.
12.7. Abbott Laboratories
12.8. Nihon Kohden Corporation
12.9. Smith & Nephew plc
12.10. B. Braun Melsungen AG

13. DataM Intelligence
13.1 Appendix
13.2 About Us and Services
13.3Contact Us